BTIG Initiates Coverage On Hims & Hers Health with Buy Rating, Announces Price Target of $35

Benzinga · 01/07 17:09
BTIG analyst David Larsen initiates coverage on Hims & Hers Health (NYSE:HIMS) with a Buy rating and announces Price Target of $35.